Reply to U.R. Mansmann et al and M.-W. An et al

Affiliations

Comment

Laurent Claret et al. J Clin Oncol. 2013.

. 2013 Dec 1;31(34):4374-5.

doi: 10.1200/JCO.2013.52.5733. Epub 2013 Oct 28.

No abstract available

Comment on

Evaluation of tumor-size response metrics to predict overall survival in Western and Chinese patients with first-line metastatic colorectal cancer.
Claret L, Gupta M, Han K, Joshi A, Sarapa N, He J, Powell B, Bruno R. Claret L, et al. J Clin Oncol. 2013 Jun 10;31(17):2110-4. doi: 10.1200/JCO.2012.45.0973. Epub 2013 May 6. J Clin Oncol. 2013. PMID: 23650411
Application of tumor measurement-based metrics in the real world.
An MW, Mandrekar SJ, Sargent DJ. An MW, et al. J Clin Oncol. 2013 Dec 1;31(34):4374. doi: 10.1200/JCO.2013.52.3662. Epub 2013 Oct 28. J Clin Oncol. 2013. PMID: 24166528 No abstract available.
Methodologic diligence is needed to define and validate tumor-size response metrics to predict overall survival in first-line metastatic colorectal cancer.
Mansmann UR, Laubender RP. Mansmann UR, et al. J Clin Oncol. 2013 Dec 1;31(34):4373-4. doi: 10.1200/JCO.2013.51.2954. Epub 2013 Oct 28. J Clin Oncol. 2013. PMID: 24166531 No abstract available.